MétaCan
Menu
Back to cohort
Record W2173601762 · doi:10.1212/wnl.0000000000001991

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

2015· article· en· W2173601762 on OpenAlexfundno aff
Sebastian Palmqvist, Henrik Zetterberg, Niklas Mattsson, Per Johansson, Lennart Minthon, Mattias Olsson, Oskar Hansson, Håkan Toresson, Katarina Nägga, Erik Stomrud, Christer Nilsson, Maria H Nilsson, Daniel Lindqvist, Susanna Vestberg, Shorena Janelidze, Ulf Andréasson, Danielle van Westen, Jimmy Lätt, Peter Mannfolk, Markus Nilsson, Olof Strandberg, Pia C. Sundgren, Freddy Ståhlberg, Olof Lindberg, Eric Westman, Lars‐Olof Wahlund, Per Wollmer, Ruben Smith, Tomas Olsson, Michael D. Weiner, Paul Aisen, Clifford R. Jack, William Jagust, Arthur W. Toga, Laurel Beckett, Robert C. Green, Anthony Gamst, Andrew J. Saykin, John C. Morris, William Z. Potter, Tom Montine, Ronald Petersen, Ronald G. Thomas, Michael Donohue, Sarah Walter, Anders M. Dale, Matt A. Bernstein, Joel P. Felmlee, Nick C. Fox, Paul M. Thompson, Norbert Schuff, Gene E. Alexander, Charles DeCarli, Dan Bandy, Robert A. Koeppe, Norm Foster, Eric M. Reiman, Kewei Chen, Nigel J. Cairns, Lisa Taylor‐Reinwald, Les Shaw, Virginia M.‐Y. Lee, Magdalena Korecka, Karen Crawford, Scott Neu, Danielle Harvey, John Kornak, Tatiana Foroud, Steven G. Potkin, Li Shen, Zaven Kachaturian, Richard Frank, Peter J. Snyder, Susan Molchan, Jeffrey Kaye, Sara Dolen, Joseph Quinn, Lon S. Schneider, Sonia Pawluczyk, Bryan M. Spann, James M. Brewer, Helen Vanderswag, Judith L. Heidebrink, Joanne Lord, Kris Johnson, Rachelle S. Doody, Javier Villanueva‐Meyer, Munir Chowdhury, Yaakov Stern, Lawrence S. Honig, Karen L. Bell, Mark A. Mintun, Stacy Schneider, Daniel Marson, Randall Griffith, David A. Clark, Hillel Grossman, Cheuk Y. Tang, George Marzloff, Leyla deToledo‐Morrell, Raj C. Shah, Ranjan Duara, Daniel Varón, Peggy Roberts CAN, Marilyn S. Albert, Nicholas Kozauer, Maria Zerrate, Henry Rusinek, Mony J. de Leon, Susan M De Santi, P. Murali Doraiswamy, Jeffrey R. Petrella, Marilyn Aiello, S. R. Arnold, Jason H. Karlawish, David A. Wolk, Charles D. Smith, Curtis A. Given, Peter Hardy, Oscar L. Lopez, MaryAnn Oakley, Donna M. Simpson, M. Saleem Ismail, Connie Brand, Jennifer Richard, Ruth A. Mulnard, Gaby Thai, Catherine Mc-Adams-Ortiz, Ramon Diaz‐Arrastia, Kristen Martin-Cook, Michael D. Devous, Allan I. Levey, James J. Lah, Janet S. Cellar, Jeffrey M. Burns, Heather S. Anderson, Mary M. Laubinger, Liana Apostolova, Daniel Silverman, Po H. Lu, Neill R. Graff‐Radford, Francine Parfitt, Heather Johnson, Martin R. Farlow, Scott Herring, Ann Marie Hake, Christopher H. van Dyck, Martha G. MacAvoy, Amanda L. Benincasa, Howard Chertkow, Howard Bergman, Chris Hosein, Sandra E. Black, Bojana Stefanovic, Curtis Caldwell, Ging‐Yuek Robin Hsiung, Howard Feldman, Michele Assaly, Andrew Kertesz, John Rogers, Dick Trost, Charles Bernick, Donna Munic, Chuang‐Kuo Wu, Nancy Johnson, Marsel Mesulam, Carl Sadowsky, Walter Martínez, Teresa Villena, Raymond Scott Turner, Kathleen Johnson, Brigid Reynolds, Reisa A. Sperling, Dorene M. Rentz, Keith A. Johnson, Allyson Rosen, Jared Tinklenberg, Wes Ashford, Marwan Sabbagh, Donald J. Connor, Sandra A. Jacobson, Ronald Killiany, Alexander Norbash, Anil K. Nair, Thomas O. Obisesan, Annapurni Jayam‐Trouth, Paul Wang, Alan J. Lerner, Leon Hudson, Paula Ogrocki, Evan Fletcher, Owen Carmichael, Smita Kittur, Michael Borrie, T‐Y Lee, Robert Bartha, Sterling C. Johnson, Sanjay Asthana, Cynthia M. Carlsson, Adrian Preda, Dana Nguyen, Pierre N. Tariot, Adam Fleisher, Stephanie Reeder, Vernice Bates, Horacio Capote, Michelle Rainka, Barry Hendin, Douglas W. Scharre, Maria Kataki, Earl A. Zimmerman, Dzintra Celmins, Alice D. Brown, Godfrey D. Pearlson, Karen Blank, Karen Anderson, Robert B. Santulli, Jessica Englert, Jeff D. Williamson, Kaycee M. Sink, Franklin Watkins, Brian R. Ott, Edward G. Stopa, Geoffrey Tremont, Stephen Salloway, Paul Malloy, Stephen Correia, Howard J. Rosen, Jacobo Mintzer, Crystal Flynn Longmire, Kenneth Spicer

Bibliographic record

VenueNeurology · 2015
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
FundersNational Institute on AgingCanadian Institutes of Health Research
KeywordsBiomarkerMedicineDementiaInternal medicineAlzheimer's diseasePosterior cingulateCerebrospinal fluidOncologyPrecuneusAmyloid (mycology)NeuroimagingPathologyPositron emission tomographyDiseaseNuclear medicineCognitionPsychiatryBiology

Abstract

fetched live from OpenAlex

OBJECTIVE: To compare the diagnostic accuracy of CSF biomarkers and amyloid PET for diagnosing early-stage Alzheimer disease (AD). METHODS: From the prospective, longitudinal BioFINDER study, we included 122 healthy elderly and 34 patients with mild cognitive impairment who developed AD dementia within 3 years (MCI-AD). β-Amyloid (Aβ) deposition in 9 brain regions was examined with [18F]-flutemetamol PET. CSF was analyzed with INNOTEST and EUROIMMUN ELISAs. The results were replicated in 146 controls and 64 patients with MCI-AD from the Alzheimer's Disease Neuroimaging Initiative study. RESULTS: The best CSF measures for identifying MCI-AD were Aβ42/total tau (t-tau) and Aβ42/hyperphosphorylated tau (p-tau) (area under the curve [AUC] 0.93-0.94). The best PET measures performed similarly (AUC 0.92-0.93; anterior cingulate, posterior cingulate/precuneus, and global neocortical uptake). CSF Aβ42/t-tau and Aβ42/p-tau performed better than CSF Aβ42 and Aβ42/40 (AUC difference 0.03-0.12, p<0.05). Using nonoptimized cutoffs, CSF Aβ42/t-tau had the highest accuracy of all CSF/PET biomarkers (sensitivity 97%, specificity 83%). The combination of CSF and PET was not better than using either biomarker separately. CONCLUSIONS: Amyloid PET and CSF biomarkers can identify early AD with high accuracy. There were no differences between the best CSF and PET measures and no improvement when combining them. Regional PET measures were not better than assessing the global Aβ deposition. The results were replicated in an independent cohort using another CSF assay and PET tracer. The choice between CSF and amyloid PET biomarkers for identifying early AD can be based on availability, costs, and doctor/patient preferences since both have equally high diagnostic accuracy. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that amyloid PET and CSF biomarkers identify early-stage AD equally accurately.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.026

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.012
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.092
GPT teacher head0.387
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations387
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeurologySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207